Is the Options Market Predicting a Spike in Williams-Sonoma Stock?
SNOA Stock | USD 2.85 0.06 2.06% |
About 62% of Sonoma Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Sonoma Pharmaceuticals stock suggests that many investors are alarmed at this time. The current market sentiment, together with Sonoma Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Sonoma Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Sonoma |
Investors need to pay close attention to Williams-Sonoma stock based on the movements in the options market lately.
Read at finance.yahoo.com
Sonoma Pharmaceuticals Fundamental Analysis
We analyze Sonoma Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sonoma Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sonoma Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Sonoma Pharmaceuticals is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Sonoma Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sonoma Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Sonoma Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Sonoma Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Sonoma Pharmaceuticals Related Equities
SBFM | Sunshine Biopharma | 11.32 | ||||
UPC | Universe Pharmaceuticals | 7.82 | ||||
LFCR | Lifecore Biomedical | 4.73 | ||||
PTPI | Petros Pharmaceuticals | 3.85 | ||||
DERM | Journey Medical | 3.27 | ||||
AKAN | Akanda Corp | 1.49 | ||||
SGIOY | Shionogi | 0.76 | ||||
TKNO | Alpha Teknova | 0.69 | ||||
SHPH | Shuttle Pharmaceuticals | 1.14 | ||||
SXTC | China SXT | 2.56 | ||||
LOVFF | Cannara Biotech | 4.44 | ||||
CPHI | China Pharma | 5.00 |
Complementary Tools for Sonoma Stock analysis
When running Sonoma Pharmaceuticals' price analysis, check to measure Sonoma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonoma Pharmaceuticals is operating at the current time. Most of Sonoma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Sonoma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonoma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Sonoma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |